Efficacy of Location-Based Features for Survival Prediction of Patients With Glioblastoma Depending on Resection Status.
BraTS2019
artificial neural network
feature selection
glioblastoma
machine learning
radiomics
tumor location
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2021
2021
Historique:
received:
19
03
2021
accepted:
14
06
2021
entrez:
23
7
2021
pubmed:
24
7
2021
medline:
24
7
2021
Statut:
epublish
Résumé
Cancer stands out as one of the fatal diseases people are facing all the time. Each year, a countless number of people die because of the late diagnosis of cancer or wrong treatments. Glioma, one of the most common primary brain tumors, has different aggressiveness and sub-regions, which can affect the risk of disease. Although prediction of overall survival based on multimodal magnetic resonance imaging (MRI) is challenging, in this study, we assess if and how location-based features of tumors can affect overall survival prediction. This approach is evaluated independently and in combination with radiomic features. The process is carried out on a data set entailing MRI images of patients with glioblastoma. To assess the impact of resection status, the data set is divided into two groups, patients were reported as gross total resection and unknown resection status. Then, different machine learning algorithms were used to evaluate how location features are linked with overall survival. Results from regression models indicate that location-based features have considerable effects on the patients' overall survival independently. Additionally, classifier models show an improvement in prediction accuracy by the addition of location-based features to radiomic features.
Identifiants
pubmed: 34295809
doi: 10.3389/fonc.2021.661123
pmc: PMC8290179
doi:
Types de publication
Journal Article
Langues
eng
Pagination
661123Commentaires et corrections
Type : ErratumIn
Informations de copyright
Copyright © 2021 Soltani, Bonakdar, Shakourifar, Babaie and Raahemifar.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Front Neurosci. 2017 Oct 06;11:543
pubmed: 29056896
Sci Rep. 2017 Oct 30;7(1):14331
pubmed: 29085044
Eur Radiol. 2017 Oct;27(10):4188-4197
pubmed: 27778090
Radiology. 2016 Feb;278(2):563-77
pubmed: 26579733
Sci Rep. 2019 Jan 31;9(1):1103
pubmed: 30705340
Med Biol Eng Comput. 2020 Aug;58(8):1767-1777
pubmed: 32488372
J Neurol Sci. 2008 Jun 15;269(1-2):180-3
pubmed: 18255100
Neuro Oncol. 2016 Mar;18(3):417-25
pubmed: 26188015
Sci Data. 2017 Sep 05;4:170117
pubmed: 28872634
Radiology. 2016 Sep;280(3):880-9
pubmed: 27326665
Front Comput Neurosci. 2020 Apr 08;14:25
pubmed: 32322196
Eur Radiol Exp. 2018 Nov 14;2(1):36
pubmed: 30426318
J Cell Mol Med. 2020 Apr;24(7):3807-3821
pubmed: 32065482
Cancer Genet. 2012 Dec;205(12):613-21
pubmed: 23238284
Radiology. 2013 May;267(2):560-9
pubmed: 23392431
Brainlesion. 2018;10670:358-368
pubmed: 30016377
IEEE Trans Med Imaging. 2015 Oct;34(10):1993-2024
pubmed: 25494501
Front Comput Neurosci. 2020 Aug 04;14:61
pubmed: 32848682
Cancer Res. 2017 Nov 1;77(21):e104-e107
pubmed: 29092951
Sci Rep. 2017 Sep 4;7(1):10353
pubmed: 28871110
IEEE Trans Med Imaging. 2010 Jun;29(6):1310-20
pubmed: 20378467
AJNR Am J Neuroradiol. 2018 Feb;39(2):208-216
pubmed: 28982791
Front Comput Neurosci. 2019 Nov 08;13:73
pubmed: 31780915
Radiat Oncol. 2018 Oct 5;13(1):197
pubmed: 30290849
PeerJ. 2018 Nov 22;6:e5982
pubmed: 30498643
J Neurooncol. 2014 Aug;119(1):207-14
pubmed: 24828264